These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pioglitazone inhibits platelet function and potentiates the effects of aspirin: a prospective observation study. Mongan J; Mieszczanska HZ; Smith BH; Messing SP; Phipps RP; Francis CW Thromb Res; 2012 Jun; 129(6):760-4. PubMed ID: 22225857 [TBL] [Abstract][Full Text] [Related]
4. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. Shenkman B; Einav Y; Salomon O; Varon D; Savion N Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512 [TBL] [Abstract][Full Text] [Related]
5. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients. Tseng CH; Huang TS Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579 [No Abstract] [Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity. Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610 [TBL] [Abstract][Full Text] [Related]
7. Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes. Peters Harmel AL; Kendall DM; Buse JB; Boyle PJ; Marchetti A; Lau H Curr Med Res Opin; 2004; 20(2):215-23. PubMed ID: 15006017 [TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone on lipid and lipoprotein metabolism. Betteridge DJ Diabetes Obes Metab; 2007 Sep; 9(5):640-7. PubMed ID: 17697057 [TBL] [Abstract][Full Text] [Related]
9. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood. Zhang QH; Das K; Siddiqui S; Myers AK Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590 [TBL] [Abstract][Full Text] [Related]
10. The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation. Li D; Chen K; Sinha N; Zhang X; Wang Y; Sinha AK; Romeo F; Mehta JL Cardiovasc Res; 2005 Mar; 65(4):907-12. PubMed ID: 15721871 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
12. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations]. Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287 [TBL] [Abstract][Full Text] [Related]
13. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116 [TBL] [Abstract][Full Text] [Related]
14. Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis. Borgwardt K; Bonifatius S; Gardemann A Nutr Res; 2008 Aug; 28(8):523-31. PubMed ID: 19083455 [TBL] [Abstract][Full Text] [Related]
15. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study. Davidson JA; Perez A; Zhang J; Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus. Cavender MA; Lincoff AM Am J Cardiovasc Drugs; 2010; 10(4):209-16. PubMed ID: 20653327 [TBL] [Abstract][Full Text] [Related]